Scientists have utilized CRISPR technology to engineer bacteria that can detect tumor DNA in living organisms. This method, termed "CATCH", allows bacteria to identify DNA released by colorectal tumors, thriving in the presence of cancerous cells and dying off when none are present.
Researchers at UC Santa Cruz, have developed an innovative RNA liquid biopsy that enhances early cancer detection by targeting RNA "dark matter" in the bloodstream. This breakthrough could revolutionize early cancer diagnosis, guide precise treatments, and even aid in detecting other diseases like Alzheimer's.
Researchers have found that artificial intelligence aids radiologists in detecting more breast cancer cases in mammograms than traditional methods. This AI-integrated approach not only increased cancer detection by 4% but also reduced reading time by half. Furthermore, AI significantly lowered false positives.
Gamma delta T cells in the immune system are adept at identifying and eliminating cancer cells. Patients with higher levels of these cells in their tumors generally have better outcomes. Researchers have determined the conditions that enable these T cells to recognize cancer cells.
In a pioneering study, Stanford Medicine researchers have identified predictable and sequential genetic changes that occur in cells leading to cancer. This could open the door for earlier diagnosis and intervention, potentially halting the disease's development.
The University of Edinburgh's research suggests that the positioning of certain immune cells within lung tumours could predict patient survival and treatment response. This could enhance the efficacy of immunotherapies, which currently fail in 80% of lung cancer cases. This research could significantly improve the success of immunotherapies.
The U.S. Food and Drug Administration (FDA) has enhanced the approval parameters for Bristol Myers Squibb's Reblozyl, paving the way for its broader application in treating myelodysplastic syndromes (MDS).
Newly published research link malfunctioning BRCA genes to several cancers and, using advanced sequencing, have discovered 'reciprocal pairs' in these cancers, paving the way for enhanced genetic insights and potential cancer treatments.
Researchers from the UC Davis Comprehensive Cancer Center have identified microRNA-22 (miR-22) as a promising new treatment for hepatocellular carcinoma, the most prevalent type of liver cancer.
Positive early-stage trial results suggest that Epkinly, a dual-acting cancer immunotherapy from AbbVie and Genmab, could soon offer a new treatment option for patients with follicular lymphoma.
Tumor is the abnormal growth of tissues as a result of excessive division of cells. Benign and malignant tumors are different; not all are cancerous.
Chemotherapy, widely used against cancer, is a treatment method consisting of one or more drugs. It consist anticancer drugs to destroy cancer cells.